Market Dashboard

S&P 500 equity research overview

Securities Tracked
468
Avg P/E Ratio
34.8x
Total Market Cap
$58.7T

Top Momentum

View All
TickerPrice1M ReturnScore
CMA$88.67+0.0%34
CZR$29.07+40.8%17
MRNA$55.97+33.4%79
CF$120.13+26.5%48
LYB$67.37+21.4%16
KEYS$284.26+20.5%62
APA$32.97+19.9%51
OXY$55.58+19.1%22
NFLX$94.89+16.5%-0
EOG$132.51+16.4%12

Top Quality

View All
TickerROED/EScore
AMAT38.9%0.3372
ALL39.5%0.2572
AFL13.1%0.4365
AIG7.4%0.2464
AME14.6%0.2460

Sector Distribution

Technology69
Industrials60
Healthcare55
Consumer Discretionary54
Financials52
Consumer Staples29
Real Estate28
Utilities28
Materials21
Communication Services21
Energy20

Momentum Score Distribution

<-5
157
-5~0
42
0~5
41
5~10
61
>10
174

Recent Research Reports

ABBVBuybullish

ABBV Equity Research Report

AbbVie represents a compelling dividend-focused pharmaceutical investment with consistent earnings outperformance and strong fundamentals despite facing Humira biosimilar headwinds. We recommend **BUY** with a 12-month target price of $260, driven by the successful transition to newer franchises including Skyrizi/Rinvoq, solid pipeline execution, and an attractive 3.04% dividend yield supported by robust cash generation.

3/12/2026
ABBVBuybullishTP: $235.00

ABBV Equity Research Report

AbbVie demonstrates solid momentum with positive returns across all timeframes and maintains its position as a defensive healthcare stalwart trading near historical highs. Despite competitive headwinds in key therapeutic areas, the company's diversified pipeline and strong market position in immunology support a **HOLD** recommendation with a 12-month target price of $235.

3/12/2026
AIGSellbearish

Scenario Analysis: Federal reserve cuts rates by .25 basis points

AIG faces headwinds from lower investment returns on its insurance float as interest rates decline, reducing the yield on new bond investments. While the insurer may benefit from some valuation multiple expansion, the fundamental pressure on insurance investment income and net interest margins outweighs these positives.

3/12/2026
ALLSellbearish

Scenario Analysis: Federal reserve cuts rates by .25 basis points

Allstate as a property & casualty insurer will be negatively impacted by lower investment returns on its substantial insurance float and reserves. The company's investment income, which is a key component of profitability, will decline as its bond portfolio rolls over into lower-yielding securities.

3/12/2026
AFLSellbearish

Scenario Analysis: Federal reserve cuts rates by .25 basis points

Aflac's insurance business model relies heavily on investment returns from its float, which will decline in a lower rate environment as new investments yield less. The company's net interest margins on insurance reserves will compress, negatively impacting profitability despite potential benefits to its equity valuation.

3/12/2026

Recent News

MMCneutralGlobeNewswire

Nickel Mining Industry Report 2026: Production by Country, Prices, Companies, Major Operating Mines, Competitive Landscape, Major Exploration and Development Projects 2025-2035

3/12/2026
CMAneutralBusiness Wire

Tennessee Titans Renew Subscription of Evolv Express® at Nissan Stadium

3/12/2026
GOOGLpositiveMT Newswires

Market Chatter: UK Regulators Press Meta, TikTok, Snap, YouTube to Boost Child Safety Measures

3/12/2026
GOOGLneutral24/7 Wall St.

Cramer: Why does Meta need 78,000 employees if AI makes them 10x more productive?

3/12/2026
CMAneutralWorld Construction Network

King Salman Park secures $3bn global investor backing for mixed-use district

3/12/2026
MMCpositiveGlobeNewswire

GURU Organic Energy Reports Record Q1 Revenue of $8.8 Million and Third Consecutive EBITDA-Positive Quarter

3/12/2026
MMCneutralGlobeNewswire

Verano Announces Fourth Quarter and Full Year 2025 Financial Results

3/12/2026
MMCneutralGlobeNewswire

Aya Gold & Silver Announces Commencement of Boumadine Feasibility Study and Accelerates Project Development

3/12/2026